A citation-based method for searching scientific literature

Tomasz Trybek, Agnieszka Walczyk, Danuta Gąsior-Perczak, Iwona Pałyga, Estera Mikina, Artur Kowalik, Kinga Hińcza, Janusz Kopczyński, Magdalena Chrapek, Stanisław Góźdź, Aldona Kowalska. Endocrinology 2019
Times Cited: 11







List of co-cited articles
68 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.
Bryan R Haugen, Erik K Alexander, Keith C Bible, Gerard M Doherty, Susan J Mandel, Yuri E Nikiforov, Furio Pacini, Gregory W Randolph, Anna M Sawka, Martin Schlumberger,[...]. Thyroid 2016
54

BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence.
Mingzhao Xing, Rengyun Liu, Xiaoli Liu, Avaniyapuram Kannan Murugan, Guangwu Zhu, Martha A Zeiger, Sara Pai, Justin Bishop. J Clin Oncol 2014
390
36


TERT promoter mutations in thyroid cancer.
Rengyun Liu, Mingzhao Xing. Endocr Relat Cancer 2016
183
36

Prognostic implication of BRAF and TERT promoter mutation combination in papillary thyroid carcinoma-A meta-analysis.
Huy Gia Vuong, Ahmed M A Altibi, Uyen N P Duong, Lewis Hassell. Clin Endocrinol (Oxf) 2017
50
36

Effects of Coexistent BRAFV600E and TERT Promoter Mutations on Poor Clinical Outcomes in Papillary Thyroid Cancer: A Meta-Analysis.
Shinje Moon, Young Shin Song, Ye An Kim, Jung Ah Lim, Sun Wook Cho, Jae Hoon Moon, Seokyung Hahn, Do Joon Park, Young Joo Park. Thyroid 2017
68
36

Dynamic Risk Stratification in Patients with Differentiated Thyroid Cancer Treated Without Radioactive Iodine.
Denise P Momesso, Fernanda Vaisman, Samantha P Yang, Daniel A Bulzico, Rossana Corbo, Mario Vaisman, R Michael Tuttle. J Clin Endocrinol Metab 2016
111
36

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
27


Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer.
Mingzhao Xing, Ali S Alzahrani, Kathryn A Carson, David Viola, Rossella Elisei, Bela Bendlova, Linwah Yip, Caterina Mian, Federica Vianello, R Michael Tuttle,[...]. JAMA 2013
549
27


Association between BRAF V600E mutation and recurrence of papillary thyroid cancer.
Mingzhao Xing, Ali S Alzahrani, Kathryn A Carson, Young Kee Shong, Tae Yong Kim, David Viola, Rossella Elisei, Bela Bendlová, Linwah Yip, Caterina Mian,[...]. J Clin Oncol 2015
300
27

Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013.
Hyeyeun Lim, Susan S Devesa, Julie A Sosa, David Check, Cari M Kitahara. JAMA 2017
753
27

Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Paradigm Shift to Reduce Overtreatment of Indolent Tumors.
Yuri E Nikiforov, Raja R Seethala, Giovanni Tallini, Zubair W Baloch, Fulvio Basolo, Lester D R Thompson, Justine A Barletta, Bruce M Wenig, Abir Al Ghuzlan, Kennichi Kakudo,[...]. JAMA Oncol 2016
752
27

The changing incidence of thyroid cancer.
Cari M Kitahara, Julie A Sosa. Nat Rev Endocrinol 2016
375
27

TERT, BRAF, and NRAS in Primary Thyroid Cancer and Metastatic Disease.
Miguel Melo, Adriana Gaspar da Rocha, Rui Batista, João Vinagre, Maria João Martins, Gracinda Costa, Cristina Ribeiro, Francisco Carrilho, Valeriano Leite, Cláudia Lobo,[...]. J Clin Endocrinol Metab 2017
66
27

A germline mutation in SRRM2, a splicing factor gene, is implicated in papillary thyroid carcinoma predisposition.
Jerneja Tomsic, Huiling He, Keiko Akagi, Sandya Liyanarachchi, Qun Pan, Blake Bertani, Rebecca Nagy, David E Symer, Benjamin J Blencowe, Albert de la Chapelle. Sci Rep 2015
53
18

DICER1 Mutations and Differentiated Thyroid Carcinoma: Evidence of a Direct Association.
Meilan M Rutter, Pranati Jha, Kris Ann P Schultz, Amy Sheil, Anne K Harris, Andrew J Bauer, Amanda L Field, James Geller, D Ashley Hill. J Clin Endocrinol Metab 2016
61
18


Germline HABP2 Mutation Causing Familial Nonmedullary Thyroid Cancer.
Sudheer Kumar Gara, Li Jia, Maria J Merino, Sunita K Agarwal, Lisa Zhang, Maggie Cam, Dhaval Patel, Electron Kebebew. N Engl J Med 2015
91
18

SRGAP1 is a candidate gene for papillary thyroid carcinoma susceptibility.
Huiling He, Agnieszka Bronisz, Sandya Liyanarachchi, Rebecca Nagy, Wei Li, Yungui Huang, Keiko Akagi, Motoyasu Saji, Dorota Kula, Anna Wojcicka,[...]. J Clin Endocrinol Metab 2013
53
18

A germline mutation (A339V) in thyroid transcription factor-1 (TITF-1/NKX2.1) in patients with multinodular goiter and papillary thyroid carcinoma.
Elly S W Ngan, Brian H H Lang, Tingting Liu, Cathy K Y Shum, Man-Ting So, Danny K C Lau, Thomas Y Y Leon, Stacey S Cherny, Sophia Y Tsai, Chung-Yau Lo,[...]. J Natl Cancer Inst 2009
73
18


Familial non-medullary thyroid cancer: unraveling the genetic maze.
Samantha Peiling Yang, Joanne Ngeow. Endocr Relat Cancer 2016
56
18

Risk of cancer by ATM missense mutations in the general population.
Sarah Louise Dombernowsky, Maren Weischer, Kristine Højgaard Allin, Stig Egil Bojesen, Anne Tybjaerg-Hansen, Børge Grønne Nordestgaard. J Clin Oncol 2008
51
18

CHEK2 mutations and the risk of papillary thyroid cancer.
Monika Siołek, Cezary Cybulski, Danuta Gąsior-Perczak, Artur Kowalik, Beata Kozak-Klonowska, Aldona Kowalska, Małgorzata Chłopek, Wojciech Kluźniak, Dominika Wokołorczyk, Iwona Pałyga,[...]. Int J Cancer 2015
63
18

Response to therapy of papillary thyroid cancer of known BRAF status.
Aldona Kowalska, Agnieszka Walczyk, Artur Kowalik, Iwona Pałyga, Danuta Gąsior-Perczak, Tomasz Trybek, Janusz Kopczyński, Maciej Kajor, Estera Mikina, Monika Szymonek,[...]. Clin Endocrinol (Oxf) 2017
12
18

Papillary thyroid cancer: time course of recurrences during postsurgery surveillance.
Cosimo Durante, Teresa Montesano, Massimo Torlontano, Marco Attard, Fabio Monzani, Salvatore Tumino, Giuseppe Costante, Domenico Meringolo, Rocco Bruno, Fabiana Trulli,[...]. J Clin Endocrinol Metab 2013
174
18

Variants in the ATM-CHEK2-BRCA1 axis determine genetic predisposition and clinical presentation of papillary thyroid carcinoma.
Anna Wójcicka, Małgorzata Czetwertyńska, Michał Świerniak, Joanna Długosińska, Monika Maciąg, Agnieszka Czajka, Kinga Dymecka, Anna Kubiak, Adam Kot, Rafał Płoski,[...]. Genes Chromosomes Cancer 2014
38
18

Identification of a novel germline FOXE1 variant in patients with familial non-medullary thyroid carcinoma (FNMTC).
Joana S Pereira, Joana Gomes da Silva, Rute Alexandra Tomaz, António Evaristo Pinto, Maria João Bugalho, Valeriano Leite, Branca Maria Cavaco. Endocrine 2015
37
18

The polymorphism rs944289 predisposes to papillary thyroid carcinoma through a large intergenic noncoding RNA gene of tumor suppressor type.
Jaroslaw Jendrzejewski, Huiling He, Hanna S Radomska, Wei Li, Jerneja Tomsic, Sandya Liyanarachchi, Ramana V Davuluri, Rebecca Nagy, Albert de la Chapelle. Proc Natl Acad Sci U S A 2012
191
18

Novel Approaches to Thyroid Cancer Treatment and Response Assessment.
Ravinder K Grewal, Alan Ho, Heiko Schöder. Semin Nucl Med 2016
15
18

Advances in Hypoxia-Inducible Factor Biology.
Hani Choudhry, Adrian L Harris. Cell Metab 2018
248
18

TERT promoter mutations and Ki-67 labeling index as a prognostic marker of papillary thyroid carcinomas: combination of two independent factors.
Michiko Matsuse, Tomonori Yabuta, Vladimir Saenko, Mitsuyoshi Hirokawa, Eijun Nishihara, Keiji Suzuki, Shunichi Yamashita, Akira Miyauchi, Norisato Mitsutake. Sci Rep 2017
28
18

Overall Survival of Papillary Thyroid Carcinoma Patients: A Single-Institution Long-Term Follow-Up of 5897 Patients.
Yasuhiro Ito, Akira Miyauchi, Minoru Kihara, Mitsuhiro Fukushima, Takuya Higashiyama, Akihiro Miya. World J Surg 2018
65
18


Cancer statistics, 2019.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2019
18

BRAF mutation in thyroid cancer.
M Xing. Endocr Relat Cancer 2005
906
18

Prognostic effects of TERT promoter mutations are enhanced by coexistence with BRAF or RAS mutations and strengthen the risk prediction by the ATA or TNM staging system in differentiated thyroid cancer patients.
Young Shin Song, Jung Ah Lim, Hoonsung Choi, Jae-Kyung Won, Jae Hoon Moon, Sun Wook Cho, Kyu Eun Lee, Young Joo Park, Ka Hee Yi, Do Joon Park,[...]. Cancer 2016
91
18

Testing for BRAF (V600E) Mutation in Thyroid Nodules with Fine-Needle Aspiration (FNA) Read as Suspicious for Malignancy (Bethesda V, Thy4, TIR4): a Systematic Review and Meta-analysis.
Pierpaolo Trimboli, Lorenzo Scappaticcio, Giorgio Treglia, Leo Guidobaldi, Massimo Bongiovanni, Luca Giovanella. Endocr Pathol 2020
5
40

Regulation of mutant TERT by BRAF V600E/MAP kinase pathway through FOS/GABP in human cancer.
Rengyun Liu, Tao Zhang, Guangwu Zhu, Mingzhao Xing. Nat Commun 2018
83
18


TERT promoter mutations are a major indicator of recurrence and death due to papillary thyroid carcinomas.
Martyn Bullock, Yan Ren, Christine O'Neill, Anthony Gill, Adam Aniss, Mark Sywak, Stan Sidhu, Leigh Delbridge, Diana Learoyd, Florent de Vathaire,[...]. Clin Endocrinol (Oxf) 2016
37
18

BRAF V600E Confers Male Sex Disease-Specific Mortality Risk in Patients With Papillary Thyroid Cancer.
Fei Wang, Shihua Zhao, Xiaopei Shen, Guangwu Zhu, Rengyun Liu, David Viola, Rossella Elisei, Efisio Puxeddu, Laura Fugazzola, Carla Colombo,[...]. J Clin Oncol 2018
27
18

Prognostic Significance of TERT Promoter Mutations in Papillary Thyroid Carcinomas in a BRAF(V600E) Mutation-Prevalent Population.
Seung Eun Lee, Tae Sook Hwang, Yoon-La Choi, Hye Seung Han, Wan Seop Kim, Min Hye Jang, Suk Kyeong Kim, Jung Hyun Yang. Thyroid 2016
42
18

BRAF(V600E) Is Correlated with Recurrence of Papillary Thyroid Microcarcinoma: A Systematic Review, Multi-Institutional Primary Data Analysis, and Meta-Analysis.
Yufei Chen, Peter M Sadow, Hyunsuk Suh, Kyu Eun Lee, June Young Choi, Yong Joon Suh, Tracy S Wang, Carrie C Lubitz. Thyroid 2016
52
18



Prediction of thyroid hormone supplementation after thyroid lobectomy.
Doh Young Lee, Jungirl Seok, Woo-Jin Jeong, Soon-Hyun Ahn. J Surg Res 2015
36
18

Detecting Recurrence Following Lobectomy for Thyroid Cancer: Role of Thyroglobulin and Thyroglobulin Antibodies.
Amit Ritter, Aviram Mizrachi, Gideon Bachar, Igor Vainer, Ilan Shimon, Dania Hirsch, Talia Diker-Cohen, Hadar Duskin-Bitan, Eyal Robenshtok. J Clin Endocrinol Metab 2020
15
18


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.